25 results on '"Larkin, Brenda"'
Search Results
2. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial
3. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
4. Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
5. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
6. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
7. A Critical Shortage of Surgical Technologists Creates Collaboration Between Rivals
8. The ins and outs of body piercing
9. Interpreting Arterial Blood Gases Successfully
10. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
11. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax ® challenge in vaccinia-naïve and vaccinia-immune individuals
12. Modified vaccinia Ankara: potential as an alternative smallpox vaccine
13. Translating Evidence to Practice for Mechanical Venous Thromboembolism Prophylaxis
14. Evaluating a Case Study Using Bloomʼs Taxonomy of Education
15. COVID‐19 Response Unites Perioperative Teams at a Recently Merged Health Care System.
16. Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.
17. Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
18. DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
19. DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial.
20. Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses.
21. Home Study Program The ins and outs of body piercing.
22. Measuring outcomes of evidence-based practice for mechanical venous thromboembolitic prophylaxis.
23. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals
24. An HIV Vaccine: As We Build It, Will They Come?
25. Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.